Implanet receives FDA, CE Mark approval for JAZZ Lock — 3 insights

Bordeaux, France-based Implanet received FDA clearance and CE mark for its Jazz Lock implant.

Advertisement

Here are three insights:

 

1. The Jazz Lock is designed for degenerative spinal disorder surgery.

 

2. The implant is based on the polyester sublaminar braid platform.

 

3. With this implant, the JAZZ technological platform extends to the cervical spine.

 

“A result of collaboration with leading surgeons, Jazz Lock represents a major breakthrough: an innovative IP protected design offering surgeons a fusion device that no other company currently can,” said Régis Le Couedic, product development and manufacturing director, Implanet.

 

More articles on devices:
InVivo Therapeutics adds UVA Health System as INSPIRE study site: 4 takeaways
Anika Therapeutics names CMO, COO: 4 points
CareCredit, DePuy Synthes Mitek Sports Medicine form agreement — 3 highlights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.